Prevention of vascular calcification: Is pyrophosphate therapy a solution

Kidney International

Volumn 79, Issue 5, 2011, Pages 490-493

  Persy, Veerle P ^a   McKee, Marc D ^b  

^a Hugin Mugin Research   (Belgium)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; OSTEOCALCIN; OSTEOPONTIN; PYROPHOSPHATE;

ARTERY CALCIFICATION; BLOOD VESSEL CALCIFICATION; BONE MINERALIZATION; CHRONIC KIDNEY DISEASE; DRUG HALF LIFE; EXTRACELLULAR MATRIX; HUMAN; MINERALIZATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; UREMIA;

EID: 79951649837     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.478     Document Type: Note

References (10)

1. Zoccali C, Mallamaci F, Tripepi G. Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 2004; 15 (Suppl 1): S77-S80. (Pubitemid 38018461)
2. Moe S, Drueke T, Cunningham J et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int2006;69: 1945-1953. (Pubitemid 43924257)
3. O'Neill WC, Lomashvili KA, Malluche HH et al. Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int2011;79: 512-517.
4. Speer MY, McKee MD, Guldberg RE et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 2002; 196: 1047-1055. (Pubitemid 35231763)
5. Harmey D, Hessle L, Narisawa S et al. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol2004;164: 1199-1209. (Pubitemid 38387787)
6. Hashiba H, Aizawa S, Tamura K et al. Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects. Ther Apher Dial 2006; 10:59-64.
7. Ariyoshi T, Eishi K, Sakamoto I et al. Effectof etidronic acid on arterial calcification in dialysis patients. Clin Drug Investig2006;26:215-222.
8. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740. (Pubitemid 37098542)
9. Moe SM, O'Neill KD, Resterova M et al. Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant 2004; 19: 2387-2393. (Pubitemid 39214138)
10. Essalihi R Dao HH, Gilbert LA et al. Regression of medial elastocalcinosis in rat aorta: a new vascular function for carbonic anhydrase. Circulation 2005; 112: 1628-1635.